AI Article Synopsis
- Pregnancy-associated plasma protein-A (PAPP-A) levels lower than 0.4 multiples of the median (MoMs) in the first trimester are linked to an increased risk of neonatal abnormalities, particularly small for gestational age (SGA).
- A study involving 8,460 pregnant women found that those with low PAPP-A levels had higher mean age, lower gestational age, and lower birth weight, compared to those with higher levels.
- The research determined that a PAPP-A level of 0.25 MoMs was the best cutoff for predicting SGA, with a sensitivity of 84.7% and specificity of 68.6%.
Article Abstract
Background: It is suggested that pregnancy-associated plasma protein-A (PAPP-A) levels below the fifth percentile or less than 0.4 multiples of the median (MoMs) during the first trimester are closely associated with higher risk for neonatal abnormalities. We assessed the value of PAPP-A within the first trimester for predicting pregnancy outcome.
Methods: In a historical cohort study, we assessed 8460 consecutive pregnant women recruited for chromosomal abnormalities screening within the first trimester at Fertility Infertility and Perinatology Research Center, in Ahvaz Jundishapur University of Medical Sciences between April 2014 and April 2015. The women were categorized into two groups: pregnant women with PAPP-A levels below 0.4 multiples of MOM (n = 237) and those with higher levels of PAPP-A (n = 237).
Results: The median value of MOM PAPP-A was 0.82 ± 0.78, with 237 women having MOM PAPP-A lower than 0.4. Compared to women with MOM PAPP-A higher than 0.4, those with lower MOM PAPP-A had higher mean age, lower gestational age and lower birth weight. The prevalence of small for gestational age (SGA) was higher in women with MOM PAPP-A <0.4 compared to others. According to the ROC curve analysis, MOM PAPP-A <0.4 had a high value for predicting SGA. Best cutoff value for MOM PAPP-A to predict SGA was shown to be 0.25, yielding a sensitivity of 84.7% and a specificity of 68.6.
Conclusion: Measuring the serum level of MOM PAPP-A during the first trimester is a valuable marker for predicting adverse outcomes of pregnancy such as SGA.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Early Prediction of Gestational Diabetes Mellitus and Insulin Therapy Requirement Using First-Trimester PAPP-A and Free β-hCG MoMs Levels: A Retrospective Case-Control Study.
J Clin Med
December 2024
Department of Perinatology, University of Health Sciences Etlik Zübeyde Women's Health Care Training and Research Hospital, 06010 Ankara, Turkey.
To evaluate the association between gestational diabetes mellitus (GDM), including insulin-dependent GDM with pregnancy-associated plasma protein-A (PAPP-A) multiples of the median (MoM) and free beta human chorionic gonadotropin (free β-hCG) MoM levels, and to assess their potential as predictive risk factors. This retrospective study included 2588 women with singleton pregnancies who underwent combined first-trimester screening, along with the 50 g glucose challenge test (GCT) and a 100 g oral glucose tolerance test (OGTT) between 24 and 28 weeks of gestation. Patients were initially divided into four groups based on the glucose screening results, and PAPP-A and free β-hCG MoMs were compared between these groups.
View Article and Find Full Text PDFFirst-Trimester PLGF and PAPP-A and the Risk of Placenta-Mediated Complications: PREDICTION Prospective Study.
J Obstet Gynaecol Can
December 2024
Reproduction, Mother and Child Health Unit, CHU De Québec - Université Laval Research Center, Université Laval, Quebec, QC, Canada; Department of Obstetrics and Gynecology, Faculty of Medicine, Université Laval, Quebec City, Canada. Electronic address:
Objectives: To estimate the association between low first-trimester maternal serum placental growth factor (PlGF) and pregnancy-associated plasma protein A (PAPP-A) and the risk of placenta-mediated complications.
Methods: We performed a secondary analysis of PREDICTION study including nulliparous participants recruited at 11-14 weeks of pregnancy. First-trimester PlGF and PAPP-A were reported in multiples of the median (MoM) adjusted for maternal characteristics and gestational age.
The Association and diagnostic value between Maternal Serum Placental Markers and Placenta Previa.
Eur J Obstet Gynecol Reprod Biol X
December 2024
The Fourth Clinical Medical School of Zhejiang Chinese Medical University, Hangzhou, Zhejiang 310053, China.
Article Synopsis
- * Data from 137 hospitalized women showed that those with placenta previa had significantly higher levels of free β-hCG and AFP compared to a control group, while PAPP-A levels did not significantly differ.
- * ROC curve analysis confirmed some diagnostic value of FT-Free β-hCG and ST-Free β-hCG for identifying placenta previa, with AUC values indicating moderate effectiveness.
Combined detection of serum adiponectin and pregnancy-associated plasma protein A for early prediction of gestational diabetes mellitus.
Medicine (Baltimore)
October 2024
Department of Laboratory Medicine, Zhongshan City People's Hospital, Zhongshan, China.
Early diagnosis of gestational diabetes mellitus (GDM) reduces the risk of adverse perinatal and maternal outcomes. At present, the value of serum adiponectin (ADP) and pregnancy-associated plasma protein A (PAPP-A) in clinical practice for the diagnosis of GDM in early pregnancy is unclear. To investigate the predictive value of serum ADP and PAPP-A in GDM.
View Article and Find Full Text PDFEarly prediction of gestational diabetes mellitus using first trimester maternal serum pregnancy-associated plasma protein-a: A cross-sectional study.
Health Sci Rep
October 2024
Department of Midwifery and Reproductive Health, School of Nursing and Midwifery Shahid Beheshti University of Medical Sciences Tehran Iran.
Article Synopsis
- The study investigates the effectiveness of pregnancy-associated plasma protein-A (PAPP-A) in predicting gestational diabetes mellitus (GDM) during the first trimester of pregnancy, as current testing methods may be delayed.
- By analyzing serum PAPP-A levels in 344 pregnant women using a Bayesian statistical model, researchers sought to evaluate PAPP-A's diagnostic accuracy without relying on the gold standard glucose tolerance test.
- Results indicated that PAPP-A showed high sensitivity (92%) and specificity (81%) for detecting GDM, suggesting it could be a valuable early screening tool for this condition.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!